日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The buried S2 apex of SARS-CoV-2 spike elicits an immunodominant germline-restricted public antibody response

SARS-CoV-2刺突蛋白中埋藏的S2顶端可诱导产生免疫优势的、受种系限制的公众抗体反应。

Park, Suncheol; Mischka, Jacob; Okba, Nisreen; Abbad, Anass; Yuan, Meng; Srivastava, Komal; Gleason, Charles; Mulder, Lubbertus C F; Copps, Jeffrey; Saam, Katrina; Bangaru, Sandhya; Krammer, Florian; Wilson, Ian A; Simon, Viviana; Ward, Andrew B

Seasonal vaccine-induced immunity shows preserved cross-reactivity to H3N2 subclade K in adults

季节性疫苗诱导的免疫力在成人体内对H3N2亚型K仍保持交叉反应性。

Wilson, Adria; Lerman, Brian; Ramsamooj, Reima; Mischka, Jacob; Ehrenhaus, Jordan; Aracena, Ashley; Figueroa, Yusuf; Farrugia, Keith; Gonzalez-Reiche, Ana S; Nardulli, Jessica; Khalil, Zain; Gleason, Charles; Hermann, Eniko; Srivastava, Komal; Sordillo, Emilia Mia; van Bakel, Harm; Abbad, Anass; Krammer, Florian; Simon, Viviana

Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysis

XBB.1.5 COVID-19 单价疫苗的人类单克隆抗体反应图谱:B 细胞分析

Fantin, Raianna F; Clark, Jordan J; Cohn, Hallie; Jaiswal, Deepika; Bozarth, Bailey; Rao, Vishal; Civljak, Alesandro; Lobo, Igor; Nardulli, Jessica R; Srivastava, Komal; Yong, Jeremy S; Andreata-Santos, Robert; Bushfield, Kaitlyn; Lee, Edward S; Singh, Gagandeep; Kleinstein, Steven H; Krammer, Florian; Simon, Viviana; Bajic, Goran; Coelho, Camila H

XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies.

XBB.1.5 单价疫苗可诱导对 SARS-CoV-2 变种(如 HV.1 和 JN.1)以及 SARS-CoV-1 的持久交叉反应,但产生的 XBB.1.5 特异性抗体有限

Carreño Juan Manuel, Lerman Brian, Singh Gagandeep, Abbad Anass, Yellin Temima, Ehrenhaus Jordan, Fried Miriam, Nardulli Jessica R, Kang Hyun Min, Mulder Lubbertus C F, Gleason Charles, Srivastava Komal, Simon Viviana, Krammer Florian

A Surrogate Enzyme-Linked Immunosorbent Assay to Select High-Titer Human Convalescent Plasma for Treating Immunocompromised Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern.

用于选择高滴度人类康复血浆以治疗感染严重急性呼吸综合征冠状病毒 2 变异株的免疫功能低下患者的替代酶联免疫吸附试验

Dolange Victoria, Slamanig Stefan, Abdeljawad Adam, Lai Tsoi Ying, Lemus Nicholas, Singh Gagandeep, Carreño Juan Manuel, Abbad Anass, Srivastava Komal, Simon Viviana, Sachithanandham Jaiprasath, Pekosz Andrew, Sullivan David, Krammer Florian, Sun Weina, Palese Peter, González-Domínguez Irene

Challenges in Management of Pulmonary Tuberculosis in Patients with Silicosis

矽肺患者肺结核治疗面临的挑战

Dixit, Ramakant; Srivastava, Komal

T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome

T细胞表位定位揭示了SARS-CoV-2蛋白质组中进化保守区域的免疫优势

Bozkus, Cansu Cimen; Brown, Matthew; Velazquez, Leandra; Thomas, Marcus; Wilson, Eric A; O'Donnell, Timothy; Ruchnewitz, Denis; Geertz, Douglas; Bykov, Yonina; Kodysh, Julia; Oguntuyo, Kasopefoluwa Y; Roudko, Vladimir; Hoyos, David; Srivastava, Komal D; Kleiner, Giulio; Alshammary, Hala; Karekar, Neha; McClain, Christopher; Gopal, Ramya; Nie, Kai; Del Valle, Diane; Delbeau-Zagelbaum, Daniela; Rodriguez, Denise; Setal, Jessica; Carroll, Emily; Wiesendanger, Margrit; Gulko, Percio S; Charney, Alexander; Merad, Miriam; Kim-Schulze, Seunghee; Lee, Benhur; Wajnberg, Ania; Simon, Viviana; Greenbaum, Benjamin D; Chowell, Diego; Vabret, Nicolas; Luksza, Marta; Bhardwaj, Nina

Humoral SARS-CoV-2 vaccine responses are durable in solid organ transplant recipients with and without HIV

在感染或未感染HIV的实体器官移植受者中,SARS-CoV-2疫苗的体液免疫反应均持久。

Rana, Meenakshi M; Haydel, Brandy; Carrara, Gina; Gleason, Charles; Mauldin, Jacob; Srivastava, Komal; Florman, Sander S; Aberg, Judith; van Kesteren, Morgan; Mischka, Jacob; Carreño, Juan Manuel; Singh, Gagandeep; Mendu, Damodara Rao; Wajnberg, Ania; Cordon-Cardo, Carlos; Krammer, Florian; Simon, Viviana

Convergent and clonotype-enriched mutations in the light chain drive affinity maturation of a public antibody.

轻链中的趋同突变和克隆型富集突变驱动公共抗体的亲和力成熟

Rao Vishal, Sapse Iden, Cohn Hallie, Yoo Duck-Kyun, Tong Pei, Clark Jordan, Bozarth Bailey, Chen Yuexing, Srivastava Komal, Singh Gagandeep, Krammer Florian, Simon Viviana, Wesemann Duane, Bajic Goran, Coelho Camila H

SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase.

SARS-CoV-2 感染和疫苗诱导的抗体反应持续时间较长,最初会经历一个减弱期,随后进入稳定期

Srivastava Komal, Carreño Juan Manuel, Gleason Charles, Monahan Brian, Singh Gagandeep, Abbad Anass, Tcheou Johnstone, Raskin Ariel, Kleiner Giulio, van Bakel Harm, Sordillo Emilia Mia, Krammer Florian, Simon Viviana